Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Dongni Xu"'
Publikováno v:
BMC Anesthesiology, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Background The inhalational anesthetic isoflurane is commonly utilized in clinical practice, particularly in the field of pediatric anesthesia. Research has demonstrated its capacity to induce neuroinflammation and long-term behavioral disor
Externí odkaz:
https://doaj.org/article/2fcbe2e116aa4475a0a50539ebf72d08
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-14 (2024)
Abstract Histone deacetylases (HDACs) contribute significantly to the initiation, progression, and prognosis of colorectal adenocarcinoma (COAD). Additionally, HDACs regulate the tumor microenvironment, immune escape, and tumor stem cells, and are cl
Externí odkaz:
https://doaj.org/article/2d948fb330684674ad44a8ee1054f296
Autor:
Yanan Lu, Dongni Xu, Jintao Peng, Zhaofan Luo, Chujie Chen, Yuqing Chen, Huimou Chen, Minghui Zheng, Peihong Yin, Zhi Wang
Publikováno v:
EBioMedicine, Vol 44, Iss , Pp 403-418 (2019)
Background: Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease with poor prognosis, and gemcitabine-based chemotherapy remains an effective option for the majority of PDAC patients. Hepatocyte nuclear factor 1α (HNF1A) is a tumor-suppr
Externí odkaz:
https://doaj.org/article/080d32df613840f5904288dfe197a324
Autor:
Wu Xiangbo, Jianwei Luo, Pei Liuming, Yongxiang Yan, Jianfeng Zeng, Sihua Liang, Lin Shaoman, Dongni Xu, Haixuan Zhao, Wenchan Yan
Publikováno v:
Journal of Healthcare Engineering
Journal of Healthcare Engineering, Vol 2021 (2021)
Journal of Healthcare Engineering, Vol 2021 (2021)
Objective. To study the effect of a care bundle combined with continuous positive airway pressure (CPAP) in the postanesthesia care unit (PACU) on rapid recovery after pulmonary tumor resection. Methods. A total of 135 patients requiring anesthesia r
Publikováno v:
Gland Surg
Background Pancreatic ductal adenocarcinoma (PDAC) is one of malignant tumors with the worst prognosis. Surgery and adjuvant chemotherapy are the main treatments for resectable pancreatic cancer. For borderline resectable PDAC, neoadjuvant chemothera
Autor:
Ting Liu, Dongni Xu, Shuling Peng, Yi Chen, Yanan Lu, Sherif Youssif, Peizong Wang, Fengtao Ji, Fernando Hernanz, Gustavo Zucca-Matthes
Publikováno v:
Web of Science
Repositório Institucional da UNESP
Universidade Estadual Paulista (UNESP)
instacron:UNESP
Ann Transl Med . 2021 Sep;9(18):1467. doi: 10.21037/atm-21-4392.
UCrea Repositorio Abierto de la Universidad de Cantabria
Universidad de Cantabria (UC)
Ann Transl Med
Repositório Institucional da UNESP
Universidade Estadual Paulista (UNESP)
instacron:UNESP
Ann Transl Med . 2021 Sep;9(18):1467. doi: 10.21037/atm-21-4392.
UCrea Repositorio Abierto de la Universidad de Cantabria
Universidad de Cantabria (UC)
Ann Transl Med
Made available in DSpace on 2022-04-28T17:22:28Z (GMT). No. of bitstreams: 0 Previous issue date: 2021-09-01 Natural Science Foundation of Guangdong Province Background: Breast cancer is currently the leading cause of women's death. It is crucial to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14357f3a8f09ac689d35294cfdb5f6bc
HNF1A inhibition induces the resistance of pancreatic cancer cells to gemcitabine by targeting ABCB1
Autor:
Zhi Wang, Yanan Lu, Huimou Chen, Jintao Peng, Chujie Chen, Minghui Zheng, Zhaofan Luo, Yuqing Chen, Dongni Xu, Peihong Yin
Publikováno v:
EBioMedicine. 44
Background Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease with poor prognosis, and gemcitabine-based chemotherapy remains an effective option for the majority of PDAC patients. Hepatocyte nuclear factor 1α (HNF1A) is a tumor-suppre